No black box warning on record for Symlinpen

As of the latest FDA labeling reviewed, Symlinpen (PRAMLINTIDE ACETATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Symlinpen medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Severe hypoglycemia: Increased risk particularly for type 1 diabetes. Upon initiation of SYMLIN, reduce mealtime insulin dose by 50% and frequently monitor blood glucoses (5.2) . • Never share a SymlinPen between patients, even if the needle is changed (5.3) . • Do not mix SYMLIN and insulin: Mixing can alter the pharmacokinetics of both products. Administer as separat

No black box warning on record for Symlinpen

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Severe hypoglycemia: Increased risk particularly for type 1 diabetes. Upon initiation of SYMLIN, reduce mealtime insulin dose by 50% and frequently monitor blood glucoses (5.2) . • Never share a SymlinPen between patients, even if the needle is changed (5.3) . • Do not mix SYMLIN and insulin: Mixing can alter the pharmacokinetics of both products. Administer as separat

Symlinpen Black Box Warning

No black box warning on record for Symlinpen

Other warnings & precautions

Symlinpen Black Box Warning

No black box warning on record for Symlinpen

Other warnings & precautions